Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
TherapeuticsMD, Inc. has filed 1,173 SEC EDGAR filings since 16 Aug 1995

SEC filing history

Showing 426-450 of 960 matching filings.

Per page
25
Current page
18
8-K File 001-00100

CURRENT REPORT

Filing date
08 Jan 2019
Reporting date
08 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2018
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
18 Dec 2018
Reporting date
18 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Dec 2018
Reporting date
12 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-00100

CT ORDER filing

Filing date
12 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Dec 2018
Reporting date
04 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Nov 2018
Reporting date
28 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Nov 2018
Reporting date
26 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
27 Nov 2018
Reporting date
27 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Nov 2018
Reporting date
19 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Nov 2018
Reporting date
14 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Nov 2018
Reporting date
12 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
13 Nov 2018
Reporting date
13 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-00100

QUARTERLY REPORT

Filing date
08 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 Oct 2018
Reporting date
25 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
29 Oct 2018
Reporting date
29 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
25 Oct 2018
Reporting date
23 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Oct 2018
Reporting date
18 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .